Regulation of Glycogen Synthase Kinase-3 in Human Skeletal Muscle
Effects of Food Intake and Bicycle Exercise
- From the Copenhagen Muscle Research Centre, Department of Human Physiology, University of Copenhagen, Copenhagen, Denmark.
- Address correspondence and reprint requests to Jørgen F.P. Wojtaszewski, Copenhagen Muscle Research Centre, August Krogh Institute, University of Copenhagen, 13, Universitetsparken, DK-2100 Copenhagen, Denmark. Email: jwojtaszewski{at}aki.ku.dk .
Abstract
Studies of skeletal muscle from rodents performed both in vivo and in vitro suggest a regulatory role of glycogen synthase kinase (GSK) 3 in glycogen synthase (GS) activation in response to insulin. Recently, hyper-insulinemic clamp studies in humans support such a role under nearly physiological conditions. In addition, in rats the activation of GS in skeletal muscle during treadmill running is time-related to the deactivation of GSK3. We investigated whether GSK3 was deactivated in human muscle during low- (∼50% Vo2max for 1.5 h) and high-intensity (∼75% Vo2max for 1 h) bicycle exercise as well as food intake. We observed a small but significant increase in GSK3α (10-20%) activity in biopsies obtained from vastus lateralis after both low- and high-intensity exercise, whereas GSK3β activity was unaffected. Subsequent food intake increased Aktphosphorylation (∼2-fold) and deactivated GSK3α (∼40%), whereas GSK3β activity was unchanged. GS activity increased in response to both exercise and food intake. We conclude that GSK3α but not GSK3β may have a role in the regulation of GS activity in response to meal-associated hyperinsulinemia in humans. However, in contrast to findings in muscle from rats, exercise does not deactivate GSK3 in humans, suggesting a GSK3-independent mechanism in the regulation of GS activity in muscle during physical activity.
Footnotes
-
%FV, percent of fractional velocity; %I-form, percent of G6P-independent GS activity; G6P, glucose-6-phosphate; GS, glycogen synthase; GSK, GS kinase; PP, protein phosphatase.
-
- Accepted October 24, 2000.
- Received June 28, 2000.
- by the American Diabetes Association, Inc.











